名稱 | CB1/CHO |
型號 | CBP71356 |
報價 | |
特點 | CB1/CHO 凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 【新品發(fā)布】血液系統(tǒng)惡性腫瘤標(biāo)準(zhǔn)品-27基因-38位點
- 【靶點模型】AKT基因的藥物開發(fā)
- 腫瘤細(xì)胞的信息系統(tǒng)的改變特征大揭秘
- 腫瘤細(xì)胞的生長受哪些因素的作用呢?
- ?LILRB4細(xì)胞篩選模型
- 【靶點模型+診斷質(zhì)控】BTK C481S的藥物開發(fā)和診斷
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 【轉(zhuǎn)載】抗癌路漫漫,又翻一座山,名曰“CD24”
- 熱門CTLA4&PD1/L1雙靶點抗體活性檢測細(xì)胞模型
- 【產(chǎn)品推介】RANKL抗體篩選模型
聯(lián)系我們
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71356CB1/CHO
- 詳細(xì)內(nèi)容
CBP71356 | |
I. Background | |
The cannabinoid receptor CNR1 is Gs-coupled GPCRs expressed in primarily CNS and some peripheral neurones; particularly prevalent in basal ganglia, hippocampus, cerebellum, cerebral cortex and also presented in some non-neuronal cells and tissues, for example leukocytes and testis. A shorter human splice variant (411aa) has been identified in the brain and other tissues by reverse-transcriptase PCR but mRNA levels were less than 10-fold the levels of the longer isoform. The pharmacological characteristics of the isoforms are similar. | |
II. Introduction | |
Host Cell: | CHO |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10%FBS+5ug/ml puromycin |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for CB1 receptor |
Transducer: | N/A |
Ⅲ. Description of Host Cell Line | |
Organism: | Hamster |
Tissue: | Ovary |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data | |
Figure 2. CP-55940 effect on CB1/CHO-K1 clone 2. |